Mylotarg 5 mg/5mL
gemtuzumab ozogamicin · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Mylotarg is a injection, powder, lyophilized, for solution containing gemtuzumab ozogamicin at 5 mg/5mL, taken intravenous. Manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc..
Key Facts
- Brand Name
- Mylotarg
- Generic Name
- gemtuzumab ozogamicin
- NDC Code (Product)
0008-4510- Manufacturer
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- Strength
- 5 mg/5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761060
- Drug Class
- CD33-directed Immunoconjugate [EPC]
- Marketing Start
- 09/07/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Mylotarg used for?
Mylotarg contains gemtuzumab ozogamicin. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Mylotarg a controlled substance?
Mylotarg is not classified as a controlled substance by the DEA.
What is the generic name for Mylotarg?
The generic name for Mylotarg is gemtuzumab ozogamicin. There are no other listed brand versions of gemtuzumab ozogamicin.
What is the NDC code for Mylotarg 5 mg/5mL?
The NDC (National Drug Code) for Mylotarg 5 mg/5mL is 0008-4510, listed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)